Premium
Two anti‐inflammatory drugs show no benefit for bipolar depression
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30615
Subject(s) - depression (economics) , medicine , bipolar disorder , celecoxib , minocycline , adjunctive treatment , psychiatry , placebo , pharmacology , lithium (medication) , alternative medicine , biology , microbiology and biotechnology , economics , macroeconomics , antibiotics , pathology
Neither minocycline nor celecoxib was found to be more effective than placebo as an adjunctive treatment for patients with bipolar depression, according to results of a 12‐week study. The findings cast doubt on the potential benefits of anti‐inflammatory drugs in managing symptoms of bipolar depression. Study results were published in the June 2020 issue of Lancet Psychiatry .